Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

I know! And NNVC I didn't participate.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Snowy_Owl Member Profile
 
Followed By 30
Posts 4,717
Boards Moderated 0
Alias Born 10/31/08
160x600 placeholder
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/12/2021 6:16:36 AM
NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity InvestorsHub NewsWire - 10/11/2021 6:49:26 AM
NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference PR Newswire (US) - 10/5/2021 6:45:00 AM
NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap Conference PR Newswire (US) - 10/5/2021 6:45:00 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) Edgar (US Regulatory) - 9/28/2021 4:32:47 PM
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug InvestorsHub NewsWire - 9/22/2021 6:48:40 AM
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug PR Newswire (US) - 9/22/2021 6:45:00 AM
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug PR Newswire (US) - 9/22/2021 6:45:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2021 11:25:58 AM
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development InvestorsHub NewsWire - 9/14/2021 7:02:10 AM
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development PR Newswire (US) - 9/14/2021 6:53:00 AM
NanoViricides reports strong pre-clinical data for COVID-19 drugs Seeking Alpha - 3/9/2021 11:26:50 AM
NanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in ....Cont InvestorsHub NewsWire - 3/9/2021 9:30:00 AM
NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical InvestorsHub NewsWire - 3/2/2021 7:00:08 AM
NanoViricides shares rally 29% on effectiveness of COVID-19 drug candidates in cell culture studies Seeking Alpha - 3/2/2021 6:43:58 AM
NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug ....cont InvestorsHub NewsWire - 2/17/2021 7:00:00 AM
NanoViricides reports FQ2 results Seeking Alpha - 2/17/2021 6:28:57 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/16/2021 4:40:48 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 9:48:43 AM
NanoViricides’s anti-coronavirus candidate was well tolerated in animal studies Seeking Alpha - 2/8/2021 6:46:46 AM
NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP..C... InvestorsHub NewsWire - 2/8/2021 6:36:27 AM
Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants InvestorsHub NewsWire - 1/27/2021 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/26/2021 11:05:24 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/4/2021 11:45:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/10/2020 4:31:33 PM
Snowy_Owl   Thursday, 12/18/14 08:08:13 PM
Re: NewMoney post# 105810
Post # of 145665 
I know! And NNVC I didn't participate. COOP ASSETS called it wrong by a country mile.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences